Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using SMS reminders to help people with prediabetes lose weight

Official title: Impact of SMS Reminder on Weight Loss, as Part of a Hygieno-dietary Health Pathway in Patients With Prediabetes: a Randomized Controlled Trial.

Run by Centre Hospitalier Universitaire de la Réunion · NCT06477900 · Data updated 2026-11-12

This study tests if sending text message reminders about exercise and healthy eating can help people with prediabetes lose weight and avoid getting type 2 diabetes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorCentre Hospitalier Universitaire de la Réunion
Academic / other
Locations2 sites (Saint-Louis, Réunion and 1 other locations)
StatusRecruiting
StartedJanuary 22, 2025
Main results expectedJanuary 22, 2028
Study endsNovember 2028
Registry record updatedMarch 19, 2026
Trial IDNCT06477900 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years old with prediabetes who are enrolled in a health and diet care program and possess an SMS-enabled phone.

Probably not a fit

Patients currently involved in another study related to diabetes prevention or those unable to communicate in Creole or French may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention aims to assess the effectiveness of sending SMS messages with advice on physical activity and nutrition to enhance weight loss among individuals with prediabetes in La Réunion. Participants will receive 72 SMS messages as part of a health and dietary management program designed to prevent the progression to type 2 diabetes. The study seeks to provide insights into how SMS interventions can improve health outcomes and inform healthcare professionals about effective diabetes prevention strategies.

Why it matters

Potential benefit: If successful, this approach could significantly improve weight loss and reduce the risk of developing type 2 diabetes in patients with prediabetes.

How similar studies have gone: Previous studies have shown that SMS interventions can effectively support weight loss and lifestyle changes, indicating a promising approach for this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject with prediabetes as defined by HAS (fasting blood glucose \> 1.10g/L and \< 1.26g/L; or blood glucose 2h after ingestion of 10g of glucose \> 1.40g/L and \< 2g/L \[HGPO test\])
* included in a health and diet care program for patients with pre-diabetes offered by one of Réunion's CPTS (FindRisc Péi-CPTS program)
* age \> 18 years
* in possession of an SMS-enabled telephone
* able to complete self-efficacy questionnaires
* not expected to move within 12 months

Exclusion Criteria:

* participant currently being monitored in the PREDIABRUN study
* protected adults (under guardianship or curatorship)
* pregnant women
* refusal to participate in the study
* patients unable to speak Creole or French

Where it's running

  • Communauté Professionnelle Territoriale de Santé (CPTS RéSO)
    Saint-Louis, Réunion, France
    Recruiting
  • Territorial Health Professional Community (CPTS) Grand Sud
    Saint-Philippe, Reunion
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.